Page last updated: 2024-10-17

aminocaproic acid and Leukopenia

aminocaproic acid has been researched along with Leukopenia in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rowbotham, BJ1
Whitaker, AN1
Masci, PP1

Other Studies

1 other study available for aminocaproic acid and Leukopenia

ArticleYear
Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1990, Volume: 1, Issue:6

    Topics: Aminocaproic Acid; Animals; Antibodies, Monoclonal; Fibrin; Fibrin Fibrinogen Degradation Products;

1990